Trial Outcomes & Findings for Validation Study of Mean Arterial Pressure (MAP) Parameter of Masimo INVSENSOR00073 (NCT NCT06334055)

NCT ID: NCT06334055

Last Updated: 2025-07-10

Results Overview

Accuracy and precision of mean arterial pressure (MAP) measured by Masimo INVSENSOR00073 in comparison to radial arterial line.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

101 participants

Primary outcome timeframe

1-5 hours.

Results posted on

2025-07-10

Participant Flow

Participant milestones

Participant milestones
Measure
Masimo INVSENSOR00073
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo INVSENSOR00073 sensor. Masimo INVSENSOR00073: Noninvasive blood pressure monitor
Overall Study
STARTED
101
Overall Study
COMPLETED
25
Overall Study
NOT COMPLETED
76

Reasons for withdrawal

Reasons for withdrawal
Measure
Masimo INVSENSOR00073
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo INVSENSOR00073 sensor. Masimo INVSENSOR00073: Noninvasive blood pressure monitor
Overall Study
Adverse Event
4
Overall Study
Disqualified
72

Baseline Characteristics

Validation Study of Mean Arterial Pressure (MAP) Parameter of Masimo INVSENSOR00073

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Test Subject
n=25 Participants
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo INVSENSOR00073 sensor. Masimo INVSENSOR00073: Noninvasive blood pressure monitor
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
25 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
5 Participants
n=5 Participants
Sex: Female, Male
Male
20 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
5 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
5 Participants
n=5 Participants
Race (NIH/OMB)
White
7 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
6 Participants
n=5 Participants
Region of Enrollment
United States
25 participants
n=5 Participants

PRIMARY outcome

Timeframe: 1-5 hours.

Population: 9 subjects not analyzed due to incorrect software version

Accuracy and precision of mean arterial pressure (MAP) measured by Masimo INVSENSOR00073 in comparison to radial arterial line.

Outcome measures

Outcome measures
Measure
Masimo INVSENSOR00073
n=16 Participants
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo INVSENSOR00073 sensor. Masimo INVSENSOR00073: Noninvasive blood pressure monitor
Mean Arterial Pressure (MAP) Accuracy and Precision of Masimo INVSENSOR00073
1.38 Millimeters of mercury (mmHg)
Standard Deviation 4.98

Adverse Events

Masimo INVSENSOR00073

Serious events: 0 serious events
Other events: 10 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Masimo INVSENSOR00073
n=101 participants at risk
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo INVSENSOR00073 sensor. Masimo INVSENSOR00073: Noninvasive blood pressure monitor
Injury, poisoning and procedural complications
Venous sample complications
4.0%
4/101 • 1-5 hours
Injury, poisoning and procedural complications
Arterial line complications
2.0%
2/101 • 1-5 hours
Injury, poisoning and procedural complications
Infusion effects
4.0%
4/101 • 1-5 hours

Additional Information

Ahmed Alghazi, M.B.Ch.B

Masimo Corporation

Phone: 949-297-7000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place